New York Clinical Trials
Browse actively recruiting clinical trials with research sites in New York. Corterve gathers current studies from the public ClinicalTrials.gov registry so you can explore them by city and condition. Participation is voluntary; this page is general information and not medical advice.
Recruiting studies in New York
- A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV SystemNCT07194265NAAnteris Technologies Ltd.Severe Aortic StenosisThe Bronx, NY
- Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)NCT06095583PHASE3Shanghai Junshi Bioscience Co., Ltd.Limited-stage Small Cell Lung Cancer (LS-SCLC)New York, NY
- A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell HistiocytosisNCT05828069PHASE2National Cancer Institute (NCI)Recurrent Langerhans Cell HistiocytosisAlbany, NY
- A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)NCT07357727PHASE3Novartis PharmaceuticalsPrimary Myelofibrosis (PMF)Albany, NY
- A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic MigraineNCT05711394PHASE3AbbVieEpisodic MigraineAmherst, NY
- A Study to Evaluate the Effectiveness of DT-101 in Patients With DepressionNCT07300969PHASE2Draig Therapeutics LtdMajor Depressive Disorder (MDD)New York, NY
- A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast CancerNCT07100106PHASE1, PHASE2Genentech, Inc.Breast CancerEast Patchogue, NY
- A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's DiseaseNCT07011745PHASE3Bristol-Myers SquibbAlzheimer's DiseaseBrooklyn, NY
- Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal CancerNCT07392892PHASE2, PHASE3PfizerUntreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal AdenocarcinomaLong Island City, NY
- Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)NCT07437950PHASE2National Cancer Institute (NCI)Acute Myeloid LeukemiaBuffalo, NY
- Anti-GD2 ADC M3554 in Advanced Solid TumorsNCT06641908PHASE1EMD Serono Research & Development Institute, Inc.Advanced Solid TumorNew York, NY
- A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)NCT07266402PHASE3Celldex TherapeuticsChronic Inducible UrticariaNew York, NY
Clinical trials by New York metro
Popular conditions in New York
Frequently asked questions
- How do I find clinical trials in New York?
- Corterve aggregates actively recruiting clinical trials with sites in New York from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.
- Are clinical trials in New York free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- What kinds of clinical trials are available in New York?
- New York research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.